Complete Case details are given below :
Case Name : Ethics of Offshoring: Novo Nordisk and Clinical Trials in Emerging Economies
Authors : Klaus Meyer
Source : Ivey Publishing
Case ID : 909M01
Discipline : Social Enterprise
Case Length : 13 pages
Solution Sample availability : YES
Plagiarism : NO (100% Original work)
Description for case is given below :
The case outlines the conflicting ethical demands on a Danish pharmaceuticals company, Novo Nordisk, that is operating globally and is aspiring to high standards of corporate social responsibility. A recent report alleges that multinational pharmaceutical companies routinely conduct trials in developing countries under alleged unethical conditions. The company’s director reflects on how to respond to a request from a journalist for an interview. This triggers a discussion on the appropriate ethical principles and how to communicate them. As a company emphasizing corporate responsibility, the interaction with the media presents both opportunities and risks to Novo Nordisk. The case focuses on clinical trials that are required to attain regulatory approval in, for example, Europe and North America, and that are conducted at multiple sites around the world, including many emerging economies. Novo Nordisk has implemented numerous procedures to protect its various stakeholders, yet will this satisfy journalists and non-governmental organizations, and how should the company communicate with these stakeholders?
Click Here to place your order
OR
Place your order at casesolutionshub (AT)gmail(dot)com if you want to solve above case.
Cordially,
Case Solutions Hub